ArticleCancer management and research2026

Cabozantinib After Immunotherapy in Advanced Renal Cell Carcinoma. The CARE Study by the Hellenic Gu Cancer Group.

Aristotelis Bamias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.